Form 4: Abbott Director Acquires Stock Equivalent Units

Abbott Laboratories Director Patricia Paola Gonzalez acquired 246 stock equivalent units, increasing her beneficial ownership to 4,922 units.

Summary

• Patricia Paola Gonzalez, a Director at Abbott Laboratories (ABT), acquired 246 stock equivalent units.
• The transaction date for this acquisition was September 30, 2025.
• The stock equivalent units were acquired at a price of $133.94 per unit.
• These units represent director fees credited to a stock equivalent unit account under a grantor trust established by the director.
• The units earn the same return as if the fees were invested in Abbott shares and are generally paid in cash at age 65 or upon retirement from the board.
• Following this transaction, Ms. Gonzalez beneficially owns a total of 4,922 stock equivalent units.
• The reported balance of 4,922 units includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: The sentiment is slightly positive. While a routine compensation event, a director increasing their beneficial ownership, even through fees, generally indicates continued alignment with the company's performance and shareholder interests. The 10b5-1 plan adds transparency.

Positives

• A director increasing their beneficial ownership, even through compensation, can signal alignment of interests with shareholders.
• The transaction was conducted under a Rule 10b5-1(c) plan, indicating a pre-arranged, non-discretionary transaction, which can reduce concerns about opportunistic insider trading.

Future Outlook

The stock equivalent units are generally paid out in cash when the director reaches age 65 or upon their retirement from the board.

Industry Context

This filing reflects a routine director compensation event, where non-employee directors often receive a portion of their fees in equity or equity-linked instruments to align their interests with long-term shareholder value. The use of stock equivalent units and a grantor trust is a common mechanism for such compensation.

Related Party Transactions

• Director fees credited to a stock equivalent unit account under a grantor trust, representing compensation for services as a director.

Stakeholder Impact

• Shareholders: The transaction demonstrates continued alignment of a director's financial interests with the company's stock performance, potentially fostering confidence.

Next Steps

• The stock equivalent units will generally be paid out in cash upon the director reaching age 65 or retiring from the board.

Key Dates

Recommendation

This Form 4 filing details a routine compensation-related insider transaction for a director. While it shows continued alignment of interests, it does not present new fundamental information about Abbott Laboratories' operations, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this single event is unlikely to significantly alter the investment thesis.

Keywords

Abbott Laboratories, ABT, Insider Transaction, Form 4, Director Compensation, Stock Equivalent Units, Rule 10b5-1, Beneficial Ownership